Advertisement China Botanic Pharma completes chromatographic fingerprints research - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

China Botanic Pharma completes chromatographic fingerprints research

China Botanic Pharmaceutical has completed research on the chromatographic fingerprints of Siberian Ginseng series products using an analysis method that identifies the chemical characteristics of the designated medicine.

The fingerprint technology discerns the so-called forensic ‘fingerprint’ of herbal medicine components using advanced techniques including chromatographic or spectral profiling.

The profile can be used to identify different species, families, genera and cultivars of medicinal herbs, permitting reliable authentication and quality control for herbal materials.

The data developed during the work, which was completed in collaboration with Harbin Pharmaceutical Group’s Traditional Chinese Medicine No. 2 Factory, will be used by tChina Botanic to continue to improve and strengthen the quality of its Siberian Ginseng offerings.

China Botanic chairman and CEO Shaoming Li said Quality control is the key to the effectiveness of their depression remedies, which are relied on by people throughout China for their proven relief of neurological conditions.

"We have invested heavily in our production processes and this leap forward is another example of the dedication of the China Botanic team to producing the best quality herbal medicines available anywhere." Li said.